Published on in Vol 7 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/45395, first published .
Evaluating the Effect of Artificial Liver Support on Acute-on-Chronic Liver Failure Using the Quantitative Difference Algorithm: Retrospective Study

Evaluating the Effect of Artificial Liver Support on Acute-on-Chronic Liver Failure Using the Quantitative Difference Algorithm: Retrospective Study

Evaluating the Effect of Artificial Liver Support on Acute-on-Chronic Liver Failure Using the Quantitative Difference Algorithm: Retrospective Study

Journals

  1. Sun X, Wang F, Chen Z, Liao J, Yang Y, Bai L, Zhang L. Integrative anticoagulation of nafamostat mesylate in double plasma molecular adsorption system plus sequential half-dose plasmapheresis for patients with liver failure: a randomised controlled trial protocol. BMJ Open 2025;15(2):e098898 View
  2. Ma Y, Xu Y, Du L, Bai L, Tang H. Association between volume of processed plasma and total bilirubin reduction during plasma adsorption for severe liver disease. European Journal of Medical Research 2025;30(1) View